atherosclerotic disease

Related by string. * Atherosclerotic : atherosclerotic cardiovascular disease . atherosclerotic lesions . atherosclerotic vascular disease . regress atherosclerotic plaque . atherosclerotic cardiovascular / diseases . Diseases . Disease . DISEASE . DISEASES : Treat Diseases Inc. . mad cow disease . Disease Control . heart disease * occlusive atherosclerotic disease *

Related by context. All words. (Click for frequent words.) 73 atherosclerosis 72 atherosclerotic 71 atherosclerotic lesions 70 occlusive disease 69 myocardial ischemia 69 atherothrombosis 69 atherogenesis 69 vascular inflammation 69 colorectal adenoma 68 carotid plaque 68 microvascular disease 68 atherothrombotic 68 subclinical atherosclerosis 68 diabetic retinopathy DR 68 postoperative AF 68 arterial calcification 68 post thrombotic syndrome 68 thromboembolic 67 PAOD 67 distensibility 67 artery stenosis 67 vascular disease 67 carotid IMT 67 cerebral vasospasm 67 neointimal hyperplasia 67 endothelial activation 67 microvascular dysfunction 67 intermittent claudication 67 microvascular complications 66 proliferative diabetic retinopathy 66 thrombogenic 66 fibrotic disease 66 fibrosis 66 prostate cancer CaP 66 thromboembolic disease 66 fibrotic 66 atherosclerotic plaques 66 breast cancer metastasis 66 T1DM 66 endothelial dysfunction 66 left ventricular dysfunction 66 neovascularization 66 ventricular remodeling 65 coronary atherosclerosis 65 coronary artery disease 65 prothrombotic 65 carotid atherosclerosis 65 cerebral ischemia 65 pathophysiologic 65 carotid plaques 65 NAFLD 65 hepatic steatosis 65 cartilage degeneration 65 thrombus formation 65 aortic valve stenosis 65 LV dysfunction 65 chronic periodontitis 65 carotid stenosis 65 variceal bleeding 65 vasculopathy 65 platelet activation 65 β blockers 65 elevated triglyceride levels 65 prostate carcinogenesis 65 arterial thrombosis 65 metabolic abnormalities 65 knee osteoarthritis OA 65 hyperglycaemia 65 postoperative atrial fibrillation 65 Atherosclerotic 65 atherothrombotic disease 65 intima media thickness 65 ADPKD 65 intimal hyperplasia 64 atheroma 64 thrombotic complications 64 motor neuron degeneration 64 cardiac fibrosis 64 cardiovascular disease 64 metaplasia 64 hemorrhagic complications 64 renal fibrosis 64 secondary hyperparathyroidism 64 cardiovascular disease hypertension 64 platelet reactivity 64 cardiac dysfunction 64 tissue oxygenation 64 left ventricular hypertrophy 64 atrial arrhythmias 64 rhythm disturbances 64 hypercalciuria 64 thrombotic events 64 thromboembolism 64 abdominal adiposity 64 Aortic stenosis 64 primary hyperparathyroidism 64 intrahepatic 64 untreated celiac disease 64 airway remodeling 64 cardioembolic stroke 64 gallstone disease 64 premalignant 64 stratifying patients 64 functional mitral regurgitation 64 choroidal neovascularization 64 nonmelanoma skin cancers 64 amyloid deposition 64 airway hyperresponsiveness 64 choroidal neovascularization CNV 64 coronary disease 63 systolic hypertension 63 neovascular 63 arterial stiffening 63 Lp PLA 2 63 hepatic fibrosis 63 clot formation 63 autonomic dysfunction 63 vascular dysfunction 63 hyperkalemia 63 ischemic stroke 63 proliferative retinopathy 63 serum cholesterol 63 atherosclerotic plaque 63 colorectal tumors 63 distal embolization 63 cardiac repolarization 63 glucocorticoid therapy 63 myeloperoxidase 63 gastric carcinoma 63 coronary blockages 63 adrenalectomy 63 intracranial aneurysms 63 HbF 63 varices 63 Barrett esophagus BE 63 bone resorption 63 nonischemic 63 baroreflex 63 insulin resistance 63 macrovascular events 63 gastric adenocarcinoma 63 contrast induced nephropathy 63 thoracic aortic aneurysm 63 IL 1ß 63 Peripheral arterial disease 63 disc degeneration 63 colorectal carcinoma 63 thrombosis 63 osteosarcomas 63 nephrotoxicity 63 cardiac troponin 63 leukotriene pathway 63 intestinal polyps 63 upper gastrointestinal bleeding 63 atherosclerosis hardening 63 juvenile idiopathic arthritis 63 hematologic disorders 63 carcinoid 63 cirrhotic patients 63 diabetic microvascular complications 63 extrapyramidal symptoms 63 coronary artery atherosclerosis 63 macrovascular disease 63 post surgical adhesions 63 idiopathic pulmonary arterial hypertension 63 multivessel disease 63 Sjögren syndrome 63 diabetic nephropathy 63 vascular reactivity 63 allograft rejection 63 Eisenmenger syndrome 63 thyrotoxicosis 63 thrombi 62 urothelial cancer 62 cardiac conduction 62 periodontitis 62 overt nephropathy 62 infective endocarditis 62 perioperative complications 62 remyelination 62 SHPT 62 malignant transformation 62 cardiovascular morbidity 62 elevated homocysteine 62 calcified plaque 62 chronic thromboembolic pulmonary 62 hypoperfusion 62 claudication 62 heterotopic ossification 62 urolithiasis 62 cryptogenic stroke 62 stenoses 62 systemic inflammation 62 etiologic 62 Lp PLA2 62 dyslipidaemia 62 ischemic complications 62 hyperplastic 62 thrombo embolic 62 pericardial effusion 62 aminotransferases 62 hamartomas 62 gastric cardia 62 kidney urologic 62 esophagogastric 62 oxidized phospholipids 62 microalbuminuria 62 pulmonary hypertension PH 62 amyloid deposits 62 angiographically 62 antiangiogenic therapy 62 infarctions 62 postoperative delirium 62 neuronal dysfunction 62 refractory angina 62 catheter angiography 62 cerebrovascular disease 62 atherogenic dyslipidemia 62 carcinoid tumors 62 asymptomatic carotid stenosis 62 cerebral infarction 62 Subarachnoid hemorrhage 62 ischemic cardiomyopathy 62 endotoxemia 62 restenosis 62 ischemic 62 hyperparathyroidism 62 endometrial hyperplasia 62 intracoronary 62 myocardial infarction 62 calculi 62 microglial activation 62 T2DM 62 arthropathy 62 hyperhomocysteinemia 62 anti fibrotic 62 Diabetic nephropathy 62 apoptotic pathway 62 subclinical hypothyroidism 62 Diabetic neuropathy 62 mitochondrial toxicity 62 adipogenic 62 bowel resection 62 metabolic acidosis 62 torsade de pointes 62 Erythropoietic therapies may 62 elevated IOP 62 neointimal 62 axonal damage 62 tumor lysis syndrome 62 pancreatic adenocarcinoma 62 chronic pancreatitis 62 erythropoietic 62 thickness IMT 61 hyperphenylalaninemia HPA due 61 lichen planus 61 GIST tumors 61 keloid 61 metabolic disturbances 61 thromboembolic events 61 superficial femoral 61 malignant growths 61 repolarization 61 hedgehog signaling 61 hypoxemia 61 inflammatory biomarkers 61 Statin therapy 61 diabetic kidney 61 osteolytic 61 cardiac insufficiency 61 demyelination 61 infarct size 61 fatal arrhythmias 61 elevated CRP 61 Alzheimer pathology 61 silent ischemia 61 pulmonary resection 61 pheochromocytoma 61 signaling cascades 61 thickness CIMT 61 arrhythmogenic 61 neuroinflammation 61 myofibroblasts 61 extracranial 61 osteopontin 61 arterial lesions 61 pyridostigmine 61 HER2 expression 61 lung metastasis 61 postoperative pulmonary 61 hepatocellular carcinoma 61 liver fibrosis 61 diastolic dysfunction 61 chemosensitivity 61 mixed hyperlipidemia 61 decompensated heart failure 61 neoplastic lesions 61 epithelial tumors 61 cataract formation 61 HER2 overexpression 61 da mage 61 myopathies 61 aneurysm rupture 61 myocyte 61 tumor recurrence 61 esophageal cancers 61 androgen deprivation 61 atrophic gastritis 61 AAT deficiency 61 renal tumors 61 thoracic aortic aneurysms 61 intracerebral haemorrhage 61 lipid lowering therapy 61 atherosclerotic coronary 61 de ath 61 nodal metastasis 61 SSc 61 coagulation abnormalities 61 dysfunction LVSD 61 microvascular 61 colorectal carcinogenesis 61 Myelodysplastic syndromes MDS 61 arterial thickening 61 cholangiocarcinoma 61 liver resection 61 onset diabetes mellitus 61 prognostic significance 61 serum phosphate 61 lowering blood glucose 61 macrovascular complications 61 embolic stroke 61 tamponade 61 denervation 61 MGUS 61 ischemic vascular 61 arterial stiffness 61 serum calcium levels 61 prospective multicenter study 61 pharmacologic intervention 61 lung fibrosis 61 fibrin deposition 61 glomerular 61 T2D 61 basal cell nevus syndrome 61 prognostic variables 61 ventricular dysfunction 61 troponin T 61 microvascular endothelial cells 61 MGd 61 giant cell arteritis 61 urothelial carcinoma 61 osteoclast 61 hypercholesterolemia 61 pulmonary vasculature 61 thrombophilia 61 EBV infection 61 rebleeding 61 airway constriction 61 HNSCC 61 thrombolytic agents 61 nonalcoholic steatohepatitis NASH 61 lipid levels 61 DVT PE 61 aortic dissections 61 neurogenic 61 neurotrophic 61 antiplatelet drugs 61 parathyroid 61 opioid analgesia 61 CMV infection 61 tumoral 61 NF kappaB activation 61 Endothelial dysfunction 61 mucinous 61 VTEs 61 KIF6 carriers 61 lupus nephritis 61 stratify patients 61 fatty acid oxidation 61 glaucomatous 61 cirrhosis liver failure 61 prostate carcinoma 61 coronary vessels 61 ventricular arrhythmia 61 renal scarring 61 underlying pathophysiology 61 cranial irradiation 61 chronic myocardial ischemia 61 metabolic syndrome MetS 61 lumbar spinal stenosis 61 venous blood clots 61 haemodynamic 61 reblockage 61 tortuosity 61 reperfusion injury 60 antihypertensive therapy 60 left ventricular LV 60 Shy Drager syndrome 60 Venous thromboembolism 60 colorectal liver metastases 60 peripheral arterial disease 60 adenocarcinomas 60 CMV infections 60 hypertrophic 60 coronary artery calcium 60 degenerative disorders 60 angiotensin receptor blockers 60 hemodynamic instability 60 atherogenic 60 keloid scars 60 vasoconstriction 60 anticoagulants blood thinners 60 vascular anomalies 60 osteochondromas 60 leiomyomas 60 dysglycemia 60 fibrinolysis 60 vProtect TM Luminal Shield 60 Chronic pancreatitis 60 elevated LDL cholesterol 60 electrical conduction 60 osteoblastic 60 systolic dysfunction 60 infarcts 60 Cardiac hypertrophy 60 valvular heart disease 60 clinically detectable 60 CP CPPS 60 aortic stiffness 60 fibrogenesis 60 thromboxane A2 60 inflammatory rheumatic 60 antiangiogenic 60 myocardial infarction stroke 60 reflux esophagitis 60 graft occlusion 60 acetabular dysplasia 60 necrotic core 60 adenomatous 60 supratentorial 60 serum urate levels 60 cardio metabolic 60 hyperoxaluria 60 HIV HCV coinfected 60 mitral regurgitation MR 60 colorectal polyps 60 hepatic cirrhosis 60 osteochondroma 60 statin therapy 60 Critical limb ischemia 60 revascularization procedures 60 severe aortic stenosis 60 albuminuria 60 hyperresponsiveness 60 intensive statin therapy 60 gastrointestinal stromal tumor 60 paclitaxel eluting stents 60 Radiofrequency ablation 60 symptomatic VTE 60 anterior uveitis 60 occlusions 60 PPAR γ 60 osteoid 60 epithelioid 60 renal dysfunction 60 bone metabolism 60 thyrotropin 60 acute decompensation 60 CTEPH 60 myocardial fibrosis 60 Mitral valve 60 acute aortic dissection 60 cardioprotection 60 metachronous 60 noncardiac 60 hyperalgesia 60 PsA 60 breast endometrial 60 IPAH 60 rFVIIa 60 colorectal adenomas 60 hematopoietic cancers 60 hyperplastic polyps 60 carotid arterial 60 vascularization 60 glycated hemoglobin levels 60 renal artery stenosis 60 outflow tract 60 pulmonary metastasis 60 platelet aggregation 60 intracerebral 60 arteries atherosclerosis 60 cardiac biomarkers 60 percutaneous interventions 60 elevated triglycerides 60 pulmonary dysfunction 60 pathologic fractures 60 esophagitis 60 Symadex 60 pulmonary artery banding 60 serum uric acid 60 bacteriuria 60 bone metastasis 60 nerve degeneration 60 thromboembolic complications 60 renal cell carcinomas 60 cardiac hypertrophy 60 posterior vitreous detachment 60 vWF 60 cystic lesions 60 occlusion CRVO 60 nonalcoholic steatohepatitis 60 adenoma 60 pelvic lymphadenectomy 60 B7 H3 60 intestinal permeability 60 thrombus aspiration 60 dyslipidemias 60 oral anticoagulation therapy 60 osteoblast 60 microbleeds 60 bypass grafting 60 hemorrhagic strokes 60 allergic inflammation 60 unresectable tumors 60 paricalcitol 60 hypercalcemia 60 riociguat 60 contractile function 60 uveal melanoma 60 plasma kallikrein 60 microglial 60 atherosclerotic lesion 60 cervical lymph nodes 60 acute coronary syndromes ACS 60 nasopharyngeal carcinoma 60 fragility fractures 60 vasodilators 60 immunopathology 60 Hypertrophy 60 E selectin 60 pressure natriuresis 60 mitral stenosis 60 interstitial fibrosis 60 torsades de pointes 60 renal insufficiency 60 Cardiopulmonary bypass 60 hypertrophic scarring 60 atherosclerotic progression 60 glycosylated hemoglobin HbA1c 60 macroalbuminuria 60 cytopenia 60 isolated systolic hypertension 60 vascular occlusion 60 geographic atrophy 60 intact parathyroid hormone 60 macrovascular 60 node metastasis 60 Fibrosis 60 bicuspid aortic valves 60 Squalamine 60 bullous 60 CYP #A# 60 myeloproliferative diseases 60 recurrent VTE 60 ERK signaling 60 coronary stenosis 60 extra articular 60 vascular abnormalities 60 precancerous condition 60 atherosclerosis narrowing 60 ovarian carcinoma 60 Hashimoto thyroiditis 60 hypercoagulable 60 somatostatin analogs 60 TNFa 60 serum calcium 60 hyperammonemia 60 dilated cardiomyopathy DCM 60 haematopoietic 60 interstitium 60 atrioventricular 60 juvenile idiopathic arthritis JIA 60 liver scarring 60 prognostic marker 60 peritumoral 60 hypervascular tumors 60 neuropathological 60 enteroviral infection 60 rtPA 60 Ischemic 60 adenomatous polyps 60 stable angina 60 peripheral artery 60 esophageal varices 60 incomplete revascularization 60 hypercalcaemia 60 neurocognitive deficits 60 recurrent glioblastoma multiforme 60 antithrombotic therapy 60 fasting glucose levels 60 carotid intima media 60 tenascin C 60 PCNSL 59 lipoprotein levels 59 paroxysmal AF 59 lipid accumulation 59 acute coronary syndromes 59 venous reflux 59 neuroinflammatory 59 β amyloid 59 biliary tract 59 familial hypercholesterolemia 59 acute coronary 59 gastroduodenal 59 vessel occlusion 59 EXJADE 59 obstructive coronary 59 coronary lesions 59 reflux disease 59 PICSO ® 59 everolimus eluting stents 59 coronary plaques 59 multicentric 59 fibrinolytic 59 prostate cancer PCa 59 corticosteroid therapy 59 malperfusion 59 rectal cancers 59 Fas ligand 59 keloid scarring 59 hyperplasia 59 generalized seizures 59 arterial plaque 59 ischemic mitral regurgitation 59 undergoing coronary angiography 59 membranous nephropathy 59 vascular endothelial 59 carotid endarterectomy 59 idiopathic pulmonary 59 collagen degradation 59 diabetes mellitus DM 59 arterial plaques 59 neuroblastomas 59 oncologic outcomes 59 atheroma volume 59 FGFs 59 renal parenchyma 59 venous insufficiency 59 DAPT 59 aortic root replacement 59 parathyroidectomy 59 microvasculature 59 oesophageal adenocarcinoma 59 VEGF expression 59 Peutz Jeghers syndrome 59 vascular calcification 59 deep vein thromboses 59 arteriosclerotic 59 seminomas 59 p# mutations 59 AT1R 59 arterial inflammation 59 premalignant lesions 59 homocysteine concentrations 59 cerebrovascular events 59 tissue fibrosis 59 Pulmonary hypertension 59 invasive candidiasis 59 AV fistulas 59 proteoglycan 59 intestinal motility 59 etiological 59 Critical Limb Ischemia CLI 59 heart arrhythmias 59 stented vessel 59 arrhythmias 59 diabetic gastroparesis 59 coronary vascular 59 venous drainage 59 neovascularisation 59 carotid artery stenting 59 Occlusive Disease 59 dissolve clots 59 antiarrhythmic 59 TGF ß1 59 CVD mortality 59 intraoperative complications 59 circulating EPCs 59 OPCAB 59 hyperinsulinemia 59 contrast echocardiography 59 axon regeneration 59 primary aldosteronism 59 Insulin resistance 59 inducible nitric oxide synthase 59 steatohepatitis 59 recanalization 59 heterotaxy 59 gastric atrophy 59 brain lesions 59 leukemia AML 59 venous thromboembolic disease 59 cardiac contractility 59 abnormal lipid 59 systemic toxicity 59 popliteal artery 59 hepatorenal syndrome 59 intracerebral hemorrhage 59 periodontal infection 59 Ascherio 59 VADT 59 erythropoiesis 59 BPS IC 59 acute myocardial infarction AMI 59 abnormal lipids 59 sirolimus 59 dentinal hypersensitivity 59 left ventricular systolic 59 narrowed carotid arteries 59 AST ALT 59 myocardial infarction MI 59 cirrhotic liver 59 Hypotension 59 infantile hemangioma 59 gastrointestinal cancers 59 leiomyoma 59 intra abdominal abscess 59 radiographic findings 59 colorectal cancer CRC 59 pulmonary emboli 59 grade cervical intraepithelial 59 ventricular arrhythmias 59 pulmonary metastases 59 GH deficiency 59 prognostic indicator 59 nitrotyrosine 59 paroxysmal atrial fibrillation 59 iron overload 59 AA Amyloidosis 59 Unstable angina 59 carotid artery stenting CAS 59 vesicoureteral reflux 59 PROactive study 59 clusterin 59 Darapladib 59 papillary renal cell carcinoma 59 pro angiogenic 59 postoperative mortality 59 artery clogging plaque 59 vasodilatation 59 inflammatory cascade 59 intrathoracic 59 intracranial stenosis 59 temporal arteritis 59 carotid artery blockage 59 thrombolytics 59 complement inhibitor eculizumab 59 saphenous vein grafts 59 serum PTH 59 Peripheral vascular disease 59 antithrombotic agents 59 dysplastic 59 acute coronary syndrome 59 Liver transplantation 59 chronic hepatitis cirrhosis 59 brain parenchyma 59 angiotensin receptor blockers ARBs 59 epithelial ovarian 59 hypercholesterolaemia 59 histological subtype 59 soluble CD# ligand 59 recurrent stroke 59 squamous cell lung cancer 59 antireflux surgery 59 Atherosclerosis 59 antiangiogenic agent 59 mutated K ras 59 coagulopathy 59 nonvertebral fracture 59 cardiovascular hospitalization 59 basal cell carcinoma BCC 59 gastric varices 59 comorbidities 59 autoantibody levels 59 deacetylase inhibitors 59 knee OA 59 hypertrophic scars 59 RAS mutations 59 C. pneumoniae 59 troponins 59 nonvertebral fractures 59 patients undergoing CABG 59 surgical revascularization 59 intestinal mucosal 59 tolvaptan 59 hyperprolactinemia 59 biliary stones 59 Pseudomonas aeruginosa infections 59 coronary vasculature 59 advanced adenomas 59 hedgehog pathway 59 nonobstructive CAD 59 acute GVHD 59 cerebrovascular diseases 59 parkinsonism 59 limb ischemia 59 uPA 59 neural degeneration 59 VEGF inhibitors 59 nonfasting triglycerides 59 aortic stenosis 59 molecular abnormalities 59 LRP5 59 thyroid dysfunction 59 insulin sensitizers 59 septal 59 carcinoids 59 nonfasting triglyceride levels 59 deferiprone 59 urinary excretion 59 recombinant tissue plasminogen 59 disease progression 59 Severe Primary IGFD 59 alteplase 59 cobiprostone 59 cognitive dysfunction 59 TGF β 59 antiplatelet therapy 59 neoplastic 59 adiponectin levels 59 fatty infiltration 59 pressor response 59 selective inhibition 59 hepatocellular 59 liver metastasis 59 recurrent DVT 59 neurological complications 59 perfusion defects 59 imatinib resistance 59 nonmelanoma skin cancer 59 treat brain aneurysms 59 gastrointestinal GI bleeding 59 monoclonal gammopathy 59 atherosclerotic cardiovascular disease 59 G6PD deficiency 59 malignant neoplasms 59 endobronchial 59 testicular cancers 59 atherosclerosis regression 59 recurrent venous thromboembolism 59 endothelial cells lining 59 antiphospholipid syndrome 59 VAPRISOL 59 peptide BNP 59 arteriography 59 potentially modifiable 59 Ventricular Tachycardia 59 arterial occlusion 59 neurologic complications 59 NSAID induced 59 pituitary adenomas 59 lesional 59 metastatic neuroendocrine tumors 59 node metastases 59 proto oncogene 59 myocardial infarctions 59 colonic mucosa 59 excitotoxicity 59 systemic amyloidosis 59 mitral regurgitation 59 cholelithiasis 59 alkalosis 59 bronchogenic carcinoma 59 prophylactic therapy 59 cardiometabolic risk 59 artherosclerosis 59 undergoing CABG 59 mTOR inhibitors 58 prostatic tissue 58 MMP9 58 antiplatelet therapies 58 chronic inflammation 58 NFTs 58 biphosphonates 58 ABCB1 58 atherosclerotic vascular disease 58 transaminase levels 58 platelet function 58 nephropathy 58 neovascular AMD 58 pulmonary embolism PE 58 cardiac myocytes 58 HeFH 58 insulin resistance syndrome 58 Intussusception 58 fibrosis scarring 58 aortic aneurysms 58 plasminogen activators 58 PSADT 58 gastric mucosal 58 radiochemotherapy 58 restenosis reblockage 58 gastric lymphoma 58 rheumatic disease 58 metastatic lesions 58 Candida infection 58 reinfarction 58 perfusion abnormalities 58 hyperacute 58 esophageal squamous cell carcinoma 58 mucociliary clearance 58 tarsal tunnel 58 MetS 58 plasma uric acid 58 direct thrombin inhibitors 58 esophageal carcinoma 58 abnormal glucose metabolism 58 biologic plausibility 58 conventional angiography 58 nonsense mutation 58 Brodmann Area 58 endoleaks 58 degenerative retinal diseases 58 distant metastases 58 superior mesenteric artery 58 osteoporotic vertebral compression fractures 58 intraventricular 58 IL6 58 von Willebrand 58 lipid abnormalities 58 malignant pleural mesothelioma 58 Fontan procedure 58 pyelonephritis 58 thoracoscopic lobectomy 58 biochemical abnormalities 58 neurocognitive impairment 58 atherothrombotic events 58 OSAHS 58 tracheal intubation 58 antidiabetic drugs 58 cardiovascular disease CVD 58 demyelinating 58 ischemia 58 aminotransferase levels 58 metastatic malignant 58 QTc interval 58 spontaneous regression 58 prostate adenocarcinoma 58 ipsilateral stroke 58 lipid lowering therapies 58 myocardial reperfusion 58 FFR measurements 58 spinal metastases 58 hyperintense lesions 58 pleural mesothelioma 58 Coronary artery calcium 58 coronary calcification 58 advanced adenoma 58 cardiovascular 58 chloride secretion 58 vascular permeability 58 carotid stenting 58 glycemia 58 remnant lipoproteins 58 bronchial airway 58 transthyretin 58 chronic venous insufficiency 58 polyp recurrence 58 renal flares 58 adrenal suppression 58 reintervention 58 endoscopic ultrasonography 58 bacterial colonization 58 antiplatelet medications 58 impaired glucose metabolism 58 liver histology 58 metabolic dysfunction 58 tardive dyskinesia TD 58 carotid artery intima media 58 anti angiogenic drugs 58 ALI ARDS 58 TNF antagonist 58 CLA supplementation 58 atopic dermatitis AD 58 amyloid β 58 immunosuppressant therapy 58 subclinical disease 58 noncoronary 58 GPx 58 lymphangiogenesis 58 aortic atherosclerosis 58 uterine tumors 58 neoplasm 58 endometrial carcinoma 58 nutlin 3a 58 neuromotor 58 chronic GVHD 58 S#A# [002]

Back to home page